Equillium Inc (EQ)

0.7164 -0.06 (-7.48%) USD  |  NASDAQ  |  Jan 08, 16:00
0.6813 -0.04 (-4.90%) After-Hours: 20:00
More

Equillium SG&A Expense (Quarterly): 3.278M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for EQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Matinas BioPharma Holdings Inc 2.142M
Tenon Medical Inc 2.976M
Madrigal Pharmaceuticals Inc 107.58M
Relmada Therapeutics Inc 11.86M
Spero Therapeutics Inc 5.198M